TELOMERASE-DEPENDENT REACTIVATION OF DNA SYNTHESIS IN MACROPHAGES IMPLIES ALTERATION OF TELOMERES

In previous work we demonstrated that various types of cultured cells with a limited life span could not reactivate DNA synthesis in the nuclei of mouse peritoneal macrophages in heterokaryons. We now investigate the role of telomerase in the process of the macrophage nucleus reactivation in heterok...

Full description

Saved in:
Bibliographic Details
Published inCell biology international Vol. 26; no. 12; pp. 1019 - 1027
Main Authors Yegorov, Y.E., Kazimirchuk, E.V., Terekhov, S.M., Karachentsev, D.N., Shirokova, E.A., Khandazhinskaya, A.L., Meshcheryakova, J.A., Corey, D.R., Zelenin, A.V.
Format Journal Article
LanguageEnglish
Published Oxford, UK Elsevier Ltd 01.01.2002
Blackwell Publishing Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In previous work we demonstrated that various types of cultured cells with a limited life span could not reactivate DNA synthesis in the nuclei of mouse peritoneal macrophages in heterokaryons. We now investigate the role of telomerase in the process of the macrophage nucleus reactivation in heterokaryons with immortal telomerase-positive 3T3 Swiss mouse fibroblasts and human fibroblasts with introduced hTERT gene. We report that introduction of the hTERT gene into human diploid fibroblasts results in emergence of telomerase activity in these cells and the ability to induce the reactivation of DNA synthesis in the macrophage nuclei in heterokaryons. Inhibition of telomerase activity in heterokaryons by reverse transcriptase inhibitors (azidothymidine and guanosine polyphosphonate analogues) and by a 2′-O-methyl-RNA oligonucleotide anti-sense to the template region of telomerase RNA, block reactivation of DNA synthesis in macrophage nuclei without inhibiting DNA synthesis in the nuclei of fibroblasts. Our results suggest alterations (shortening or damage) in the macrophage telomere structure. As far as we know, heterokaryons with macrophages are the first cellular model for rapid investigation of the effects of telomerase inhibitors.
Bibliography:ark:/67375/WNG-BVMNJ8VP-1
ArticleID:CBIN1236
istex:188BC01743F325EFB98823C3B0D7CD07CF26CF10
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1065-6995
1095-8355
DOI:10.1006/cbir.2002.0961